Pfizer (PFE) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Louise Chen reiterated a Buy rating on Pfizer (NYSE: PFE) today and set a price target of $53. The company’s shares closed yesterday at $43.93, close to its 52-week More »

ADMA Biologics (ADMA) Receives a Buy from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on ADMA Biologics (NASDAQ: ADMA) today and set a price target of $12. The company’s shares closed yesterday at $5.29. McCarthy noted: “ADMA More »